Published in
Oxford University Press (OUP), Rheumatology, 8(58), p. 1510-1511, 2019
DOI: 10.1093/rheumatology/kez120
Oxford University Press (OUP), Rheumatology, 8(58), p. 1507-1509, 2019
DOI: 10.1093/rheumatology/kez067
Links
Tools
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply
Journal article published in 2019 by
Thomas Frisell,
Johan Askling 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 